iifl-logo

Most Read News

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App
image

Veto Switchgears And Cables Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

image

BASF India Limited has informed the Exchange about Loss of Share Certificates

image

Navneet Education Limited has informed the Exchange regarding Intimation in terms of Regulation 30 of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015.

image

NELCO Limited has informed the Exchange about Loss of Share Certificates

image

Chembond Chemicals Ltd with respect to announcement dated 12-Jan-2022, regarding Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify following:? 1. Brief details of change in shareholding pattern (if any) of listed entity. 2. Name of the entity (ies) forming part of the amalgamation/merger, details in brief such as, size, turnover etc.; 3. Whether the transaction would fall within related party transactions? If yes, whether the same is done at arms length; 4. Area of business of the entity (ies); 5. Rationale for amalgamation/ merger; 6. In case of cash consideration amount or otherwise share entitlement/exchange ratio; The response of the Company is awaited.

image

HCL Technologies Limited has informed the Exchange that Record date for the purpose of Dividend is 22-Jan-2022.

image

Black Box Limited has informed the Exchange about Schedule of meet

image

Goodluck India Limited has informed the Exchange about Schedule of meet

image

The South Indian Bank Limited has informed the Exchange about Loss of Share Certificates

image

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 17, 2022, titled Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single‐Dose Pre‐Filled Syringe.

Image
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.